Rongxin Bio-Tech Co.,Ltd(H.K.)
Hongkong RongXin Bio-Tech Co.,Ltd is identified in available sources as a company founded in 2009 with operations linked to the development and production of pharmaceutical compounds. The business profile indicates involvement across several areas within the pharmaceutical field, including the development and custom processing of APIs and intermediates for steroid hormones, as well as the sales and wholesale of APIs and intermediates. The company is also described as being engaged in the development and production of growth hormone and peptide hormones, highlighting expertise in biologically active compounds.
According to the information provided, the firm emphasizes quality and compliance as guiding principles. The description notes a commitment to meeting customer needs and integrating advanced technology as a core belief. A notable point cited is the firm’s concerted focus on secure and efficient shipping and the presence of a risk control mechanism within its business operations. The company also references integrity, creativity, and mutual benefit as part of its overarching business philosophy, signaling a goal of developing with customers globally.
The available source material outlines several core activities, including:
- Development and custom processing of APIs and intermediates for steroid hormones,
- Sales and wholesale of APIs and intermediates,
- Development and production of growth hormones and peptide hormones,
- API and intermediate inspection services, covering aspects such as purity and heavy metal testing.
Website updates are noted in the source content, with an invitation to contact the company via email for product details. While the exact logistical services are not enumerated in the available materials, the emphasis on secure shipping and risk management suggests a focus on reliable supply chain practices and quality assurance within the pharmaceuticals sector. The profile presents RongXin Bio-Tech Co., Ltd as a specialized player in the pharmaceutical and chemical spaces, with a clear orientation toward quality control, compliance, and customer collaboration on a global scale.
Location and corporate naming in the sources indicate an association with Hong Kong-based operations under the name RongXin Bio-Tech Co., Ltd (H.K.), and a stated founding year of 2009. This combination points to a company with international orientation and a portfolio anchored in steroid hormones, hormones-related products, and related API and intermediate activities.
